Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease
Yuanyuan Gu(State Key Laboratory of Pharmaceutical Biotechnology), Christopher L. Karp(Center of Molecular Immunology (Cuba)), Carl D. Langefeld(Wake Forest University), Mitchell L. Drumm(Pediatrics and Genetics), Lukas A. Huber(Innsbruck Medical University), Susan Ewart(Case Western Reserve University), Chloe L. Thio(Johns Hopkins University), H. Leighton Grimes(Cincinnati Children's Hospital Medical Center), Michael R. Knowles(University of North Carolina at Chapel Hill), Jeffrey R. Kilpatrick(Oklahoma Medical Research Foundation), Anil G. Jegga(University of Cincinnati), Bruce J. Aronow(Cincinnati Children's Hospital Medical Center), Garry R. Cutting(Johns Hopkins University), Lindsay B. Henderson(Johns Hopkins University), Marsha Wills‐Karp(Cincinnati Children's Hospital Medical Center), Leah M. Flick(Center of Molecular Immunology (Cuba)), Ilja Vietor(Innsbruck Medical University), Jing Chen(University of California San Diego), Marie-Dominique Filippi(Cincinnati Children's Hospital Medical Center), Adrienne H. Williams(Wake Forest University), Isaac T. W. Harley(Center of Molecular Immunology (Cuba)), John B. Harley(Cincinnati Children's Hospital Medical Center), Syed Hasan Arshad(Southampton General Hospital)
Cited by 133
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k